Trials / Unknown
UnknownNCT05437731
Titanium Mesh Coated With Natural Hydroxyapatite Nanocrystals in Orbital Reconstruction
Evaluation of Titanium Mesh Coated With Natural Hydroxyapatite Nanocrystals in Orbital Reconstruction (Randomized Controlled Clinical Trial)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Hams Hamed Abdelrahman · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Reconstruction of maxillofacial continuity defects has always been a challenging task for scientists and surgeons over the years. The main goal of the reconstruction of the maxillofacial region is to restore facial form, function, and full rehabilitation of occlusion and articulation. A refinement in surgical technique and methods of reconstruction has improved patients' quality of life. Aim of this study: Evaluation of titanium mesh coated with natural hydroxyapatite in orbital reconstruction.
Detailed description
Twelve patients having orbital defects will be selected. Six defects will be reconstructed using titanium mesh coated with natural hydroxyapatite nanocrystals (study group) and the other six will be treated with uncoated titanium mesh (control group). Patients will be evaluated clinically, then a radiographic follow-up will be performed immediately postoperatively and after three months to evaluate the bone density at the defect. Also, the coated and uncoated titanium mesh will be mechanically evaluated to compare the tensile strength of the two groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Coated titanium mesh | patients will undergo repairing of defects or reconstruction using the titanium mesh coated with hydroxyapatite nanocrystals. |
| OTHER | Uncoated titanium mesh | patients will undergo reconstruction using the conventional uncoated titanium mesh. |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2022-10-30
- Completion
- 2022-10-30
- First posted
- 2022-06-29
- Last updated
- 2022-06-29
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05437731. Inclusion in this directory is not an endorsement.